Related Experiment Video
Updated: Jul 27, 2026
Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption
Published on: August 16, 2016
Experimental models for the study of cardiovascular function and disease
1Cardiovascular Research, The Centre for Cardiovascular Biology and Medicine, The Rayne Institute, King's College, St Thomas' Hospital, London, SE1 7EH, UK.
Insights
Choosing the right experimental model is crucial for cardiovascular research, especially for myocardial ischemia. Understanding model limitations helps advance clinical relevance in disease studies.
Area of Science:
- Cardiovascular biology
- Experimental pathology
Background:
- Cardiovascular diseases, particularly myocardial ischemia, remain a leading cause of mortality.
- A wide array of experimental models and measurable indices exist for studying cardiovascular health and disease.
Purpose of the Study:
- To identify the strengths and weaknesses of various experimental models used in cardiovascular research.
- To highlight the paradox between data reproducibility and clinical relevance in preclinical studies.
Main Methods:
- Review and analysis of existing experimental models in cardiovascular biology.
- Evaluation of different measurable indices of function and injury.
Main Results:
- Each experimental model and endpoint presents unique advantages and disadvantages.
- Highly reproducible data from preclinical models may not always translate to clinical reality.
Conclusions:
- Selecting the most appropriate experimental system is vital for addressing specific research questions.
- Understanding the limitations of experimental models can be leveraged to improve the clinical applicability of research findings.
Abstract:
In the study of cardiovascular biology, both under conditions of health and disease, the investigator enjoys the availability of a vast range of experimental models ranging from man to a single molecule and beyond. There is also a vast spectrum of measurable indices of function and injury. This is particularly so in the case of myocardial ischemia, a disease which still contributes to the majority of deaths in the Western Hemisphere. Each experimental model, each species and each end-point has its own inherent advantages and disadvantages and appreciating these will help the investigator select the most appropriate study system for the particular question under investigation. This article endeavours to identify some of these strengths and weaknesses and reveals the frequently encountered paradox that the greater the amount and reproducibility of data the further removed is the model from clinical reality. Fortunately, however, an appreciation of this 'weakness' can often be exploited for the advancement of knowledge.
Related Concept Videos
01:29Pathophysiology of Cardiac Performance
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:27Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...